ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,059,000 | +65.5% | 22,148 | +6.1% | 0.00% | +33.3% |
| Q3 2021 | $1,244,000 | -31.9% | 20,882 | -22.0% | 0.00% | -40.0% |
| Q2 2021 | $1,826,000 | +10.2% | 26,771 | +12.1% | 0.01% | 0.0% |
| Q1 2021 | $1,657,000 | -1.3% | 23,880 | +9.3% | 0.01% | -16.7% |
| Q4 2020 | $1,679,000 | +36.7% | 21,856 | +33.1% | 0.01% | 0.0% |
| Q3 2020 | $1,228,000 | +17.7% | 16,419 | -0.9% | 0.01% | 0.0% |
| Q2 2020 | $1,043,000 | +151.9% | 16,566 | +68.2% | 0.01% | +100.0% |
| Q1 2020 | $414,000 | -48.4% | 9,850 | -44.3% | 0.00% | -25.0% |
| Q4 2019 | $803,000 | -8.5% | 17,681 | -7.8% | 0.00% | -20.0% |
| Q3 2019 | $878,000 | -24.0% | 19,177 | -2.8% | 0.01% | -28.6% |
| Q2 2019 | $1,156,000 | +16.2% | 19,724 | -11.1% | 0.01% | +16.7% |
| Q1 2019 | $995,000 | +16.4% | 22,199 | +1.1% | 0.01% | 0.0% |
| Q4 2018 | $855,000 | -29.1% | 21,961 | -16.2% | 0.01% | -25.0% |
| Q3 2018 | $1,206,000 | +1.6% | 26,199 | -3.8% | 0.01% | 0.0% |
| Q2 2018 | $1,187,000 | +23.8% | 27,231 | +12.2% | 0.01% | +33.3% |
| Q1 2018 | $959,000 | +4.6% | 24,272 | -10.1% | 0.01% | 0.0% |
| Q4 2017 | $917,000 | +45.1% | 26,989 | +8.9% | 0.01% | 0.0% |
| Q3 2017 | $632,000 | +95.7% | 24,793 | +29.6% | 0.01% | +100.0% |
| Q2 2017 | $323,000 | – | 19,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| IFP Advisors, Inc | 2 | $1,000 | 0.00% |